MM Panel Cytogenetics FISH del11q del13q IgH del17p
Comprehensive Genetic Analysis for Multiple Myeloma
The MM Panel Cytogenetics FISH test represents a cutting-edge diagnostic approach specifically designed for Multiple Myeloma patients. This sophisticated genetic analysis combines traditional cytogenetic techniques with advanced Fluorescence In Situ Hybridization (FISH) technology to provide comprehensive insights into the chromosomal abnormalities that drive Multiple Myeloma progression and treatment response.
What This Test Measures and Detects
This comprehensive panel specifically targets four critical genetic markers that significantly influence Multiple Myeloma prognosis and treatment outcomes:
- del(11q) Detection: Identifies deletions in chromosome 11q, which are associated with specific disease characteristics and treatment responses
- del(13q) Analysis: Screens for chromosome 13q deletions, a well-established prognostic marker in Multiple Myeloma
- IgH Rearrangements: Detects immunoglobulin heavy chain gene abnormalities that play crucial roles in disease pathogenesis
- del(17p) Identification: Assesses for chromosome 17p deletions, one of the most significant high-risk genetic features in Multiple Myeloma
Who Should Consider This Test
This advanced genetic panel is particularly recommended for:
- Newly diagnosed Multiple Myeloma patients requiring comprehensive genetic risk stratification
- Individuals experiencing unexplained bone pain, fatigue, or recurrent infections
- Patients with abnormal protein levels detected in blood or urine tests
- Those with a family history of hematological malignancies
- Patients requiring treatment response monitoring or relapse assessment
- Individuals planning to undergo stem cell transplantation
Clinical Benefits of Genetic Testing
Understanding your genetic profile through this comprehensive panel provides numerous clinical advantages:
- Personalized Treatment Planning: Genetic results guide oncologists in selecting the most effective therapeutic approaches
- Prognostic Stratification: Identifies high-risk genetic features that influence disease progression and survival outcomes
- Treatment Response Prediction: Helps anticipate how patients might respond to specific medications and therapies
- Risk Assessment: Provides valuable information for determining appropriate monitoring schedules and intervention timing
- Clinical Trial Eligibility: Genetic markers often determine qualification for targeted therapy trials
Understanding Your Test Results
Your MM Panel results will provide detailed information about the presence or absence of specific genetic abnormalities:
- Normal Results: Indicate absence of the tested chromosomal abnormalities, suggesting standard-risk disease characteristics
- del(17p) Positive: Identifies high-risk disease requiring more aggressive treatment approaches
- Multiple Abnormalities: The presence of several genetic changes may indicate more complex disease biology
- Treatment Implications: Specific genetic findings may guide the use of proteasome inhibitors, immunomodulatory drugs, or other targeted therapies
It’s essential to discuss your results with your hematologist or oncologist, who can provide personalized interpretation based on your complete clinical picture.
Test Pricing Information
| Test Name | Discount Price | Regular Price |
|---|---|---|
| MM Panel Cytogenetics FISH del11q del13q IgH del17p | $450 USD | $600 USD |
Nationwide Testing Availability
We proudly offer this comprehensive genetic testing service across our network of diagnostic centers throughout the United States. Our facilities are conveniently located in major metropolitan areas including:
- New York City and surrounding areas
- Los Angeles and Southern California
- Chicago and the Midwest region
- Houston and Texas locations
- Miami and Florida centers
- Additional locations nationwide
Take Control of Your Health Journey
Don’t leave your treatment decisions to chance. The genetic insights provided by our MM Panel Cytogenetics FISH test can make a significant difference in your Multiple Myeloma management strategy. Our experienced genetic counselors and oncology specialists are ready to help you understand your results and navigate your treatment options.
Ready to schedule your test? Contact us today at +1(267) 388-9828 or book your appointment online to take the first step toward personalized Multiple Myeloma care.
Note: This test requires a physician’s prescription and is not applicable for surgery preparation, pregnancy cases, or international travel documentation purposes. Sample collection involves bone marrow or peripheral blood using Sodium Heparin Vacutainer (2ml) with immediate transport requirements. Results are typically available within 5-7 business days.
